Formulation optimization focused on safety and thermostability of a single-vial bivalent Sudan Ebola virus and Marburgh Virus Vaccine

Authors

• Axel Lehrer, University of Hawaii, USA
• Teri Ann S. Wong, University of Hawaii
• Michael M. Lieberman, University of Hawaii
• Oreola Donini, Soligenix, Inc.
• Thomas Geisbert, University of Texas Medical Branch
• Albert To, University of Hawaii

Conference Dates

May 19 - 24, 2024

Abstract

Please click Additional Files below to see the full abstract.

Recommended Citation

Axel Lehrer, Teri Ann S. Wong, Michael M. Lieberman, Oreola Donini, Thomas Geisbert, and Albert To, "Formulation optimization focused on safety and thermostability of a single-vial bivalent Sudan Ebola virus and Marburgh Virus Vaccine" in "Vaccine Technology IX", Linda Lua, The University of Queensland, Australia; Charles Lutsch, Sanofi-Vaccines, France; Francesc Gòdia, Universitat Autònoma de Barcelona (UAB), Spain; Tara Tagmyer, CMC Leader, USA Eds, ECI Symposium Series, (2024). https://dc.engconfintl.org/vaccine_ix/80